<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.65.e67782</article-id>
      <article-id pub-id-type="publisher-id">67782</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Dental medicine</subject>
          <subject>Orthodontics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Evaluation of antibacterial effect of the orthodontic composite containing propolis nanoparticles in rat as an animal model</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Imani</surname>
            <given-names>Zeinab</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Sodagar</surname>
            <given-names>Ahmad</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Pourhajibagher</surname>
            <given-names>Maryam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Nader</surname>
            <given-names>Armin Hosseinpour</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Bahador</surname>
            <given-names>Abbas</given-names>
          </name>
          <email xlink:type="simple">abahador@sina.tums.ac.ir</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</addr-line>
        <institution>Tehran University of Medical Sciences</institution>
        <addr-line content-type="city">Tehran</addr-line>
        <country>Iran</country>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line content-type="verbatim">Department of Orthodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</addr-line>
        <institution>Tehran University of Medical Sciences</institution>
        <addr-line content-type="city">Tehran</addr-line>
        <country>Iran</country>
      </aff>
      <aff id="A3">
        <label>3</label>
        <addr-line content-type="verbatim">Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran</addr-line>
        <institution>Tehran University of Medical Sciences</institution>
        <addr-line content-type="city">Tehran</addr-line>
        <country>Iran</country>
      </aff>
      <aff id="A4">
        <label>4</label>
        <addr-line content-type="verbatim">Oral Microbiology Laboratory, Department of Medical Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</addr-line>
        <institution>Tehran University of Medical Sciences</institution>
        <addr-line content-type="city">Tehran</addr-line>
        <country>Iran</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Abbas Bahador, Oral Microbiology Laboratory, Department of Medical Microbiology, School of Medicine, Tehran University of Medical Sciences, 16th Azar St., Enghelab Sq., Tehran, Iran; Email: <email xlink:type="simple">abahador@sina.tums.ac.ir</email>; Tel.: +98-21 6491070</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <volume>65</volume>
      <issue>1</issue>
      <fpage>131</fpage>
      <lpage>139</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/21851700-FB1F-5611-A8B6-ECFB47ECB0CD">21851700-FB1F-5611-A8B6-ECFB47ECB0CD</uri>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>04</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>07</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Zeinab Imani, Ahmad Sodagar, Maryam Pourhajibagher, Armin Hosseinpour Nader, Abbas Bahador</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>﻿Abstract</label>
        <p><bold>Aim</bold>: The present study aimed to assess the antimicrobial eﬀects of orthodontic primer containing nano-propolis against the cariogenic bacteria in а rat model.</p>
        <p><bold>Materials and methods</bold>: Transbond XT orthodontic primer containing 0%, 1%, 5%, and 10% nano-propolis was experimentally prepared in-house. The Wistar rats we used in the study were randomly divided into four groups and their oral cavities were colonized with <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">Lactobacillus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic>. After anesthetizing the rats, one drop (10 µL) of primer containing diﬀerent concentrations of nano-propolis was applied to the labial surface of the maxillary incisor and light-cured. The orthodontic composite was applied on the primer and light-cured. One drop (10 µL) of primer containing the same concentrations of nano-propolis was again applied on the surface of composite and light-cured. The number of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> colonies in the saliva of rats was quantified at 24 h, at days 4 and 7 using plate counting.</p>
        <p><bold>Results</bold>: Primer containing 1%, 5%, and 10% of nano-propolis significantly reduced the <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> colony count at 24 h compared with the control group (<italic>p</italic>&lt;0.05). At day 4, the mean <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> colony counts in the 5% and 10% nano-propolis groups were significantly lower than that in the control group (<italic>p</italic>&lt;0.05). Primer containing 1%, 5%, and 10% (all (<italic>p</italic>&lt;0.05) of nano-propolis significantly reduced the <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> at 24 hours. Also, at day 4 the mean <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> colony counts in the 5% and 10% nano-propolis groups were significantly lower than that in the control group (<italic>p</italic>&lt;0.05). At 24 h and 4 days, the mean <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> colony count in the 1%, 5%, and 10% nano-propolis group was significantly lower than that in the control group (<italic>p</italic>&lt;0.05). No significant diﬀerence was observed in the presence of all concentrations of nano-propolis at day 7 (<italic>p</italic>&gt;0.05).</p>
        <p><bold>Conclusions</bold>: Orthodontic primer containing nano-propolis significantly reduced the colony count of cariogenic bacteria in a rat model.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>cariogenic bacteria</kwd>
        <kwd>nano-propolis</kwd>
        <kwd>composite</kwd>
        <kwd>orthodontic adhesive</kwd>
        <kwd>primer</kwd>
        <kwd>rat</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0EIBAC">
        <title>Citation</title>
        <p>Imani Z, Sodagar A, Pourhajibagher M, Nader AH, Bahador A. Evaluation of antibacterial effect of the orthodontic composite containing propolis nanoparticles in rat as an animal model. Folia Med (Plovdiv) 2023;65(1):131-139. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3897/folmed.65.e67782">10.3897/folmed.65.e67782</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="﻿Introduction" id="SECID0EUBAC">
      <title>﻿Introduction</title>
      <p>White spot lesions (<abbrev xlink:title="White spot lesions" id="ABBRID0E1BAC">WSLs</abbrev>) around the brackets are a sequela of fixed orthodontic treatment, which is aggravated by poor oral hygiene.<sup>[<xref ref-type="bibr" rid="B1 B2 B3">1–3</xref>]</sup> Based on a recent meta-analysis, the frequency of new <abbrev xlink:title="White spot lesions" id="ABBRID0EFCAC">WSLs</abbrev> and carious lesions has been reported 68% in patients undergoing fixed orthodontic treatment which is quite alarming and necessitating the attention of both patients and orthodontists to effective caries prevention programs and techniques.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup> There is a significant change in the microbiome of the dental plaque after the insertion of orthodontic fixed appliances with higher concentrations of acidogenic bacteria including <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> as well as dental plaque inhabitant bacteria such as <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> where it modifies the environment to make it less hospitable for the cariogenic bacteria, such as <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>. <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> is a pioneering colonizer and a key player in dental biofilm development as well as serves as a tether for the interaction of a variety of another oral microbiome, which colonizes the tooth surface, form dental plaque, and recognized as the etiology of both dental caries and periodontal disease. It also contributes to extra-oral diseases including infective endocarditis.<sup>[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]</sup> A predominance of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> is associated with healthy plaque biofilm without carious lesions, while <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> are associated with tooth decay. The relative balance between <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> may be an indicator of a patient’s oral health and risk for dental caries.‌<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup> Consequently, scientists and orthodontists have been especially devoted to emerging and new nanoparticle-based materials with anti-caries activities to minimize the occurrence of <abbrev xlink:title="White spot lesions" id="ABBRID0EQGAC">WSLs</abbrev>.<sup>[<xref ref-type="bibr" rid="B8">8</xref>]</sup></p>
      <p>Nanotechnology and nanoscience, the use of matter with dimensions on the atomic, molecular, and supramolecular scale, has become increasingly utilized for medical and clinical applications and has recently attracted much interest as an approach to killing or reducing the virulence of numerous microorganisms.<sup>[<xref ref-type="bibr" rid="B9">9</xref>]</sup> While some natural antimicrobial agents, such as propolis, possess greater antimicrobial activities as particle size is decreased into the nanometer scale due to the increased surface to volume ratio, the shape and structure of a nanoparticle itself and the way in which it attaches with and penetrates into microbial cells appears to also be responsible for unique microbiocidal mechanisms.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
      <p>Propolis is a mixture of buds, exudates, and other parts of plants as well as beeswax substances, and bee salivary enzymes used by bees to protect the hive from cavities and intruders. It has various activities such as antibacterial, antiviral, antifungal, antiparasitic, antioxidant, anti-inflammatory, and antiproliferative effects. In terms of antibacterial effect, the content including phenolic and flavonoids compounds is important.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup></p>
      <p>No research has been conducted on combining the orthodontic composite with nano-propolis to obtain an antimicrobial effect in an animal model and improved fixed orthodontic treatment outcomes.</p>
    </sec>
    <sec sec-type="﻿Aim" id="SECID0ESHAC">
      <title>﻿Aim</title>
      <p>The purpose of the current study was to explore a combinational orthodontic composite with nano-propolis to reduce cariogenic <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> in oral cavity of rat as an animal model. It was hypothesized that there was a significant difference between the antimicrobial property of the orthodontic composite containing nano-propolis and the original orthodontic composite against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> in a rat model.</p>
    </sec>
    <sec sec-type="materials|methods" id="SECID0E1JAC">
      <title>﻿Materials and methods</title>
      <sec sec-type="﻿Preparation of nano-propolis" id="SECID0E5JAC">
        <title>﻿Preparation of nano-propolis</title>
        <p>Nano-propolis was prepared as described previously.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> Briefly, the crude propolis was collected from honey bees from Golpayegan, Iran. Fine powder was prepared from propolis using an electric mill. An extract of propolis (10% w/v) was prepared after adding ethanol (85%) in a shaking water bath (at 37±1°C and 150 rpm) for 48 hours. Then the liquid portion was filtered through a filter paper (Whatman No. 1) and maintained at 4°C sonicated for 20 min and then evaporated in a water bath at 50°C to concentrate for the preparation of nano-propolis. The obtained nano-propolis was dried using a freeze-drying machine (Lyotrap/Plus, UK) for further usage. The morphological analysis of nano-propolis was determined using scanning electron microscopy (<abbrev xlink:title="scanning electron microscopy" id="ABBRID0ELKAC">SEM</abbrev>).</p>
      </sec>
      <sec sec-type="﻿Preparation of modified orthodontic composite" id="SECID0EPKAC">
        <title>﻿Preparation of modified orthodontic composite</title>
        <p>Transbond XT orthodontic primer (3M Unitek, Monrovia, CA, USA) was used for the preparation of the modified orthodontic composite (<abbrev xlink:title="modified orthodontic composite" id="ABBRID0EVKAC">MOA</abbrev>) containing 0%, 1%, 5%, and 10% nano-propolis. Twenty drops (50 µl ≈ 0.05 g per drop) of Transbond XT orthodontic primer were mixed with 0.00, 0.01, 0.05, and 0.1 g of nano-propolis for the preparation of the control (no nano-propolis), 1%, 5%, and 10% nano-propolis groups, respectively, using an ultrasonic bath for 30 minutes. The prepared experimental primers were transferred into microtubes, which were covered with aluminum wraps to prevent exposure to the light.</p>
      </sec>
      <sec sec-type="﻿Animal study design" id="SECID0EZKAC">
        <title>﻿Animal study design</title>
        <p>The animal experiments were done in accordance with the Animal Ethics Committee of Tehran University of Medical Sciences guideline (IR.TUMS.DENTISTRY.REC.1396.2773) Male Wistar rats (200–250 g; Pasteur Institute, Tehran, Iran) were housed one rat per cage, at 22–25°C and at 12 h light/dark cycles, under sanitary conditions with free access to water and sanitized pellet food. Rats were allowed to adapt to the animal room conditions for 1 week to the test day. All methods in the current study were carried out in accordance with relevant guidelines and regulations. To increase the accuracy of microbiological assessments, the bedding materials were autoclaved and replaced every day as well as the cages were disinfected with 10% povidone iodine solution. Based on the previous studies, the effect size (No. of rat in experimental groups) was estimated as nine rats per each nano-propolis concentrations, using power analysis with power arbitrarily set at 90%.<sup>[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]</sup> Initially, rats were infected with the test bacteria in this study.</p>
        <p>Rats were randomly assigned to either test (modified orthodontic composite containing 1, 5, and 10% of nano-propolis) or control groups (same as test without nano-propolis). Cariogenic bacteria-infected rat receiving original Transbond XT orthodontic primer instead of modified orthodontic composite containing nano-propolis served as controls (group A). The control group was set up with no nano-propolis (0%) applied. Test groups (B-D) were exposed to different concentrations of nano-propolis (1, 5, and 10%, respectively), while a control group (A) was not exposed <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
        <fig id="F1" position="float" orientation="portrait">
          <object-id content-type="arpha">D7F765B8-7ACF-5F60-8201-698381C0110E</object-id>
          <label>Figure 1.</label>
          <caption>
            <p>An animal model for assessment of the antimicrobial activity of orthodontic primer containing nano-propolis.</p>
          </caption>
          <graphic xlink:href="foliamedica-65-1-e67782-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_824085.jpg">
            <uri content-type="original_file">https://binary.pensoft.net/fig/824085</uri>
          </graphic>
        </fig>
        <p>Since the oral microbiome of the rats is different from that of human, the microbiome of the rats was removed based on the previous study.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> After that, a suspension of three test bacteria was prepared containing <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> (ATCC 10556), <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> (ATCC 25175), and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> (ATCC 4356) in an amount of 3×10<sup>8</sup>, 3×10<sup>8</sup>, and 3×10<sup>9</sup> colony forming units per milliliter (<abbrev xlink:title="colony forming units per milliliter" id="ABBRID0EPNAC">CFUs/mL</abbrev>), respectively. The oral cavity of the rats was infected with the bacterial suspension using sterile swabs for three consecutive days as described previously.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> To confirm the colonization of test bacteria in oral cavity of rats, after 24 h, saliva swab samples were collected and cultured on modified medium 10-sucrose agar, Man Rogosa and Sharpe-clindamycin ciprofloxacin, and agar Mitis Salivarius-Mutans valinomycin agar, and to determine the presence of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, respectively as described previously.<sup>[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]</sup> The rats harboring all of three test bacteria in their oral cavity (n=36) were entered to the next phase of the study.</p>
      </sec>
      <sec sec-type="﻿Application of orthodontic primer and adhesive" id="SECID0EGPAC">
        <title>﻿Application of orthodontic primer and adhesive</title>
        <p>Rats were anesthetized using intraperitoneal injection of a ketamine-xylazine cocktail. The rats were then fixed on an operating table in the supine position, their maxillary central incisor was etched with phosphoric acid (37%) for 20 s after which the central incisor was washed gently, and then dried with a cotton pellet. Next, 10 µL of primer containing nano-propolis was applied on the labial and proximal surface of central incisor and cured for 20 s using LED irradiation. A thin layer (2×2 mm) of adhesive (Transbond XT; 3M Unitek, Monrovia, CA, USA) was then applied to the area of the tooth that was primed and cured for 20 s using LED irradiation. Next, 10 µL of primer containing nano-propolis was again applied over the layer of adhesive and cured for 20 s using LED irradiation.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup></p>
        <fig id="F2" position="float" orientation="portrait">
          <object-id content-type="arpha">FFDC4821-E635-5934-AA3A-F0FA5D86899F</object-id>
          <label>Figure 2.</label>
          <caption>
            <p><abbrev xlink:title="scanning electron microscopy" id="ABBRID0E1PAC">SEM</abbrev> image of synthesized nano-propolis.</p>
          </caption>
          <graphic xlink:href="foliamedica-65-1-e67782-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_824086.jpg">
            <uri content-type="original_file">https://binary.pensoft.net/fig/824086</uri>
          </graphic>
        </fig>
        <p>To prevent separation of the adhesive from the surface of central incisors in occlusion, the central incisors of the mandible were shortened by 2 mm. The presence of adhesive on the surface of the teeth was checked after 24 h, 4 days, and 7 days, and saliva samples were collected from all rats at the designated time points (24 h, 4 days, and 7 days). To count the test bacteria (CFU/mL), plate counting method using brain heart infusion (<abbrev xlink:title="brain heart infusion" id="ABBRID0EGAAE">BHI</abbrev>) agar (Merck, Germany) was done as described previously.<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup></p>
      </sec>
      <sec sec-type="﻿Statistical analysis" id="SECID0EQAAE">
        <title>﻿Statistical analysis</title>
        <p>One-way ANOVA was run to compare the CFU/mL of test bacteria at each time point. Tukey’s post hoc test was applied to compare each two means on each dependent variable for pairwise comparisons. Data were analyzed using SPSS version 23.0 (SPSS Inc., IL, USA) and a <italic>p</italic>-value of 0.05 was considered statistically significant.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Results" id="SECID0EYAAE">
      <title>﻿Results</title>
      <p>As shown in <bold>Fig. <xref ref-type="fig" rid="F2">2</xref></bold>, the uniform shapes of nano-propolis are nano-sized particles, approximately 80-90 nm in diameter, which confirms the successful synthesis of nano-propolis. One-way ANOVA revealed a significant difference in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in the presence of different concentrations of nano-propolis at 24 h (<italic>p</italic>&lt;0.001) and day 4 (<italic>p</italic>&lt;0.001). According to the data in <bold>Fig. <xref ref-type="fig" rid="F3">3</xref></bold>, 13% (<italic>p</italic>=0.002), 54% (<italic>p</italic>&lt;0.001), and 63% (<italic>p</italic>&lt;0.001) reduction was shown in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL following exposure to 1%, 5%, and 10% concentrations of nano-propolis, respectively, in comparison with the control group at 24 h. The <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in the presence of 1% nano-propolis was significantly higher than that in the presence of 5% (<italic>p</italic>&lt;0.001) and 10% (<italic>p</italic>&lt;0.001) nano-propolis. At day 4, 17% (<italic>p</italic>=0.40), 41% (<italic>p</italic>=0.003), and 54% (<italic>p</italic>&lt;0.001) reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL was observed in the presence of 1%, 5%, and 10% nano-propolis, respectively, in comparison with the control group <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>. Also, 2% (<italic>p</italic>=0.998), 29% (<italic>p</italic>=0.206), and 23% (<italic>p</italic>=0.412) reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL was displayed in the presence of 5% and 10% nano-propolis, respectively, in comparison with the control group at day 7. Over time, the CFU concentrations of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> showed a tendency of nonsignificant decrease in all control groups at days 1 (9.10×10<sup>5</sup>), 4 (8.30×10<sup>5</sup>), and 7 (7.20×10<sup>5</sup>) (<italic>p</italic>&gt;0.05).</p>
      <fig id="F3" position="float" orientation="portrait">
        <object-id content-type="arpha">558615D6-B652-5FCA-A494-97027A53509D</object-id>
        <label>Figure 3.</label>
        <caption>
          <p>Mean and standard deviation of the number of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in terms of nanopropolis concentration and evaluation time.</p>
        </caption>
        <graphic xlink:href="foliamedica-65-1-e67782-g003.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_824087.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/824087</uri>
        </graphic>
      </fig>
      <p>According to the data in <bold>Fig. <xref ref-type="fig" rid="F4">4</xref></bold>, 14% (<italic>p</italic>=0.022), 53% (<italic>p</italic>&lt;0.001) and 62% (<italic>p</italic>&lt;0.001) reduction was shown in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL following exposure to 1%, 5% and 10% concentrations of nano-propolis, respectively, in comparison with the control group at 24 h. The <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in presence of 1% nano-propolis was significantly higher than that in the presence of 5% (<italic>p</italic>&lt;0.001) and 10% (<italic>p</italic>&lt;0.001) nano-propolis. At day 4, 17% (<italic>p</italic>=0.409), 29% (<italic>p</italic>=0.003), and 54% (<italic>p</italic>&lt;0.001) reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL was observed in the presence of 1%, 5%, and 10% nano-propolis, respectively, in comparison with the control group <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>. Also, 2% (<italic>p</italic>=0.998), 29% (<italic>p</italic>=0.206), and 23% (<italic>p</italic>=0.412) reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL was displayed in the presence of 5% and 10% nano-propolis, respectively, in comparison with the control group at day 7. Throughout the study period, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL revealed a tendency of nonsignificant decrease in all control groups at day 1 (9.20×10<sup>5</sup>), day 4 (8.50×10<sup>5</sup>), and day 7 (7.40×10<sup>5</sup>) (<italic>p</italic>&gt; 0.05).</p>
      <fig id="F4" position="float" orientation="portrait">
        <object-id content-type="arpha">1E4DBBD8-C1A5-5ACD-A141-ED88DA5BF29E</object-id>
        <label>Figure 4.</label>
        <caption>
          <p>Mean and standard deviation of the number of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in terms of nanopropolis concentration and evaluation time.</p>
        </caption>
        <graphic xlink:href="foliamedica-65-1-e67782-g004.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_824088.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/824088</uri>
        </graphic>
      </fig>
      <p>Significant reductions were seen in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in the presence of 1%, 5%, and 10% nano-propolis at 24 h (<italic>p</italic>&lt;0.05) in comparison with the control group. Exposure to 5% and 10% nano-propolis at day 4 had no significant reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL when compared with the control group. No significant reduction was observed in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in the presence of 1%, nano-propolis at day 4 (<italic>p</italic>&gt;0.05), and in the presence of 1%, 5%, and 10% nano-propolis at day 7 (<italic>p</italic>&gt;0.05) in comparison with the control group. As shown in <bold>Fig. <xref ref-type="fig" rid="F5">5</xref></bold>, there was 56% (<italic>p</italic>&lt;0.012), 43% (<italic>p</italic>&lt;0.001), and 30% (<italic>p</italic>=0.12) reduction in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> count (CFU/mL) in the presence of 10% nano-propolis at 24 h, days 4 and 7, respectively, in comparison with the control group. The difference between 1% nano-propolis and 10% nano-propolis groups was also significant at all examined times (<italic>p</italic>&lt;0.05) except day 7 (<italic>p</italic>&lt;0.554). During the study time, the <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL showed a tendency of nonsignificant decrease in all control groups at day 1 (9.50×10<sup>5</sup>), day 4 (9.00×10<sup>5</sup>), and day 7 (8.30×10<sup>5</sup>±6.0; <italic>p</italic>&gt;0.05).</p>
      <fig id="F5" position="float" orientation="portrait">
        <object-id content-type="arpha">44E61523-E72F-5566-9D45-C0FC7415AAEB</object-id>
        <label>Figure 5.</label>
        <caption>
          <p>Mean and standard deviation of the number of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> CFU/mL in terms of nanopropolis concentration and evaluation time.</p>
        </caption>
        <graphic xlink:href="foliamedica-65-1-e67782-g005.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_824089.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/824089</uri>
        </graphic>
      </fig>
    </sec>
    <sec sec-type="﻿Discussion" id="SECID0EYMAE">
      <title>﻿Discussion</title>
      <p>There are some concerns about the incidence of white spots as well as dental caries lesions during fixed orthodontic treatment.<sup>[<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]</sup> Fixed orthodontic appliances are always in direct contact with the enamel surface of tooth. Depending on the treatment plan, the duration of treatment and patient oral hygiene, the accumulation of microbial biofilm and the load of acidogenic bacteria including <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">Streptococcus</tp:taxon-name-part></tp:taxon-name></italic> species and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> increases in orthodontic patients. These bacteria reduce the pH of the biofilm structure in orthodontic patients. At the same time, topical application of sodium fluoride mouthwashes as well as enhancing oral hygiene behaviors have not had sufficient effects in preventing white spot lesions and dental caries.<sup>[<xref ref-type="bibr" rid="B20">20</xref>]</sup> In this regard, due to the possible antibacterial properties of propolis nanoparticles in preventing the occurrence of caries lesions, the present study was conducted to determine the antibacterial effects of propolis nanoparticles in composites used in orthodontics in a rat model.</p>
      <p>The main constituents of propolis associated with antimicrobial effects include flavonoids and cinnamic acids.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup> The other compounds of propolis such as aldehyde, aliphatic acid ester, carboxylic acids, cinnamic acid and its esters, ketone, terpene, alcohol, ether, hydrocarbon and phenolic, each of which exhibits antibacterial properties.<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup> In addition, the synergies between these compounds, along with the unique effects of the components themselves, are effective in counteracting the antibacterial effects of propolis. In addition, it has been shown that each of the compounds of propolis alone is effective against microorganisms and that propolis has more effects against pathogenic microorganisms than each of its components.<sup>[<xref ref-type="bibr" rid="B22 B23 B24">22–24</xref>]</sup></p>
      <p>In the present study, three bacteria <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> were used to evaluate the effects of different concentrations of nano-propolis used in orthodontic composites. <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> is usually involved in the onset of dental caries, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> is rarely seen in the early stages of caries. <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> is also associated with plaque biofilm and is one of the bacteria that is colonized in the oral cavity and helps to bind other microorganisms and plays a key role in the development of oral biofilm.<sup>[<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]</sup> This bacterium is associated with non-cariogenic plaques and competes with <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> to colonize the enamel surface.<sup>[<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]</sup></p>
      <p>The results of the present study showed that the use of composites with concentrations of 1%, 5%, and 10% of nano-propolis had specific antibacterial effects against  <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name>, <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> at each time of day 1, day 4, and day 7. Also, the antibacterial effects of composites with concentrations of 5% and 10% nano-propolis were stronger than those of composites with concentrations of 1% nano-propolis, but the effects of composites with concentrations of 5% and 10% nano-propolis were estimated to be equal to each other, which indicates that the effects are dose dependent. These results are consistent Lactobacilliwith the results reported by Akhavan et al.<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup>, which show the effects of nano-propolis on the antimicrobial properties of Transbond XT composite containing 1%, 2%, 5%, and 10% nano-propolis were investigated against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name>, <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic>. According to the results of their study, the lowest CFU/mL of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> was observed at 15 days, which decreased significantly at 2%, 5%, and 10% concentrations of nano-propolis and the CFU/mL of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> colonies at all concentrations (except 1%) was significantly reduced at day 30.<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup></p>
      <p>Over time, the CFU concentrations of test bacteria showed a tendency of nonsignificant decrease in all control groups at days 1, 4, and 7. It is possible that the exposure to environmental microbial strains and reversion of the natural oral microbiome in rats during the study period interfere with the prior implanted <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>. On the other hand, we cannot exclude the possibility that the change in rat saliva composition throughout the study period in the presence of orthodontic composite was responsible for the changes in CFU concentrations of test bacteria.<sup>[<xref ref-type="bibr" rid="B30">30</xref>]</sup> Besides aiding in the mechanical clearance of the oral microbiome, it has been shown that certain components of saliva may specifically influence the attachment and accumulation of different oral bacteria including <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> on oral surfaces, these include glycoproteins which adsorb to the tooth surface leading to the formation of the “acquired pellicle” and continually bathe the oral surfaces.<sup>[<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]</sup> This suggests that a tendency of nonsignificant decrease of CFU concentrations of test bacteria in all control groups during the study period may be associated with changes in the quantity and quality of the rat saliva in presence of orthodontic composite. Moreover, the role of environmental- and host-specific factors that dictate implanted <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name> populations in oral rat, remains to be investigated. Most research on the antibacterial effects of propolis on products such as propolis mouthwash and toothpaste has been done, and according to researchers, except in one case and differently<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup>, no study has been done on the effects of nanopropolis used in different concentrations on composites. Orthodontics has not been performed on cariogenic microorganisms.</p>
      <p>Most research on the antibacterial effects of propolis has resulted in products such as mouthwash and toothpaste, and to our knowledge, this is the first report that attempts to show the antimicrobial effect of an orthodontic composites containing different concentrations of nano-propolis against cariogenic microorganisms.</p>
      <p>Vanni et al.<sup>[<xref ref-type="bibr" rid="B33">33</xref>]</sup> reported that mouthwash containing propolis did not have a significant effect on reducing the number of bacterial colonies in multi-bacterial biofilms, which is not consistent with the present study. The reason for this difference can be related to the type of material used to induce antibacterial effects, which in the current study was nano-propolis in the composition with orthodontic adhesive and in the research of Vanni et al., it was a mouthwash and toothpaste products containing propolis in non-nano form.</p>
      <p>In another study, Netto et al.<sup>[<xref ref-type="bibr" rid="B34">34</xref>]</sup> showed that propolis mouthwash in comparison to chlorhexidine mouthwash has clear and superior effects in suppressing active carious lesions. Despite the differences in the protocols used in the two studies, the results of the present study are in line with the results of the study of Netto et al., in which the addition of 2% non-alcoholic propolis enhanced the antimicrobial activity of the mouthwash against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>.</p>
      <p>In the current study, with increasing time, the antibacterial effects of composites containing different concentrations of nano-propolis have decreased. The increase in the number of cariogenic microorganisms on day 7 compared to days 1 and 4 indicates that the antimicrobial properties of nano-propolis decreased over time to day 7, due to insufficient release of propolis nanoparticles. It seems that with increasing the concentration of nano-propolis, it may continue to release and induce antimicrobial effects, although the use of high concentrations of nano-propolis can also weaken the mechanical properties and bond strength of the orthodontics composite contain nano-propolis.</p>
      <p>According to the results of the present study, the highest levels of microbial inhibition occurred in all three bacteria, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic>, at a concentration of 10% nano-propolis. Also, concentrations of 5% and 10% of nano-propolis were significantly different only in the first day of exposure. On other days (i.e., days 4 and 7), no significant differences were observed in <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name> CFU/mL</italic>, in terms of bacterial inhibition. In other words, the antibacterial effects of these two concentrations were equal to each other. Since the use of various compounds such as nano-propolis can affect other physical and mechanical properties, including bond strength to the tooth, it seems that the best concentration for antibacterial effects is 5% nanoparticles.</p>
      <p>Malhotra et al.<sup>[<xref ref-type="bibr" rid="B35">35</xref>]</sup> explained the antibacterial effects of mouthwashes containing synthetic propolis (made in the laboratory with a 1:5 dilution of water) against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">Lactobacillus</tp:taxon-name-part></tp:taxon-name></italic> spp and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Candida">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="albicans">albicans</tp:taxon-name-part></tp:taxon-name></italic>. In another report, Duailibe et al.<sup>[<xref ref-type="bibr" rid="B36">36</xref>]</sup> have concluded that propolis extract has antimicrobial activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> and may be used as an alternative method to prevent tooth decay. The observations in the Malhotra et al.<sup>[<xref ref-type="bibr" rid="B35">35</xref>]</sup> and Duailibe et al.<sup>[<xref ref-type="bibr" rid="B36">36</xref>]</sup> studies are generally consistent with the results of the present study.</p>
      <p>The results of this study are consistent with a recent report<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> in which the 10% chitosan nanoparticles (CNPs) caused maximum inhibition of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>; 5% and 10% concentrations of CNPs had no significant difference with each other at any time point. Although the antimicrobial effects of nano-propolis with different concentrations in rat model were confirmed in the present study, it is necessary to confirm these results in a clinical trial.</p>
    </sec>
    <sec sec-type="﻿Conclusions" id="SECID0EF4AE">
      <title>﻿Conclusions</title>
      <p>Our data support the finding that orthodontic composite containing 10% nano-propolis demonstrated antibacterial activity against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="mutans">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Streptococcus">S.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="sanguinis">sanguinis</tp:taxon-name-part></tp:taxon-name></italic>, and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus" reg="Lactobacillus">L.</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species" reg="acidophilus">acidophilus</tp:taxon-name-part></tp:taxon-name></italic> up to day 7 in a rat model. To fully assess the viability of nano-propolis, future studies will focus on gauging the physical properties of orthodontic composite containing nano-propolis, such shear bond strength and adhesive remnant index.</p>
    </sec>
    <sec sec-type="﻿Acknowledgements" id="SECID0EM5AE">
      <title>﻿Acknowledgements</title>
      <p>This research was supported by Tehran University of Medical Science as a part of Dr. Zeinab Imani’s thesis (DDS).</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>﻿Disclosure statement</title>
      <p>No potential conflict of interest was reported by the authors.</p>
    </ack>
    <ref-list>
      <title>﻿References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple">1. Khoroushi M, Kachuie M. Prevention and treatment of white spot lesions in orthodontic patients. Contemp Clin Dent 2017; 8(1):11.</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple">2. Kleter GA. Discoloration of dental carious lesions (a review). Arch Oral Biol 1998; 43(8):629–32.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple">3. Zabokova-Bilbilova E, Popovska L, Kapusevska B, et al. White spot lesions: Prevention and management during the orthodontic treatment. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2014; 35:161–8.</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple">4. Sundararaj D, Venkatachalapathy S, Tandon A, et al. Critical evaluation of incidence and prevalence of white spot lesions during fixed orthodontic appliance treatment: A meta-analysis. J Int Soc Prev Community Dent 2015; 5:433–9.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple">5. Niven Jr CF, White JC. A study of streptococci associated with subacute bacterial endocarditis. J Bacteriol 1946; 51(6):790.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple">6. Ge Y, Caufield PW, Fisch GS, et al. <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> colonization correlated with caries experience in children. Caries Res 2008; 42(6):444–8.</mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple">7. Lundström F, Krasse B. <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> and lactobacilli frequency in orthodontic patients; the effect of chlorhexidine treatments. Eur J Orthod 1987; 9:109–16.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple">8. Matasa CG. Microbial attack of orthodontic adhesives. Am J Orthod Dentofacial Orthop 1995; 108(2):132–41.</mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple">9. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine 2012; 7:2767.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple">10. Afrasiabi S, Pourhajibagher M, Chiniforush N, et al. Propolis nanoparticle enhances the potency of antimicrobial photodynamic therapy against <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> in a synergistic manner. Sci Rep 2020; 10(1):1–6.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">11. Przybyłek I, Karpiński TM. Antibacterial properties of propolis. Molecules 2019; 24(11):2047.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple">12. Farshadzadeh Z, Taheri B, Rahimi S, et al. Growth rate and biofilm formation ability of clinical and laboratory-evolved colistin-resistant strains of Acinetobacter baumannii. Front Microbiol 2018; 9:153–68.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple">13. Bahador A, Ayatollahi B, Akhavan A, et al. Antimicrobial efficacy of silver nanoparticles incorporated in an orthodontic adhesive: an animal study. Front Dentistry 2020; 17(14):1.</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple">14. Sodagar A, Akhavan A, Pourhajibagher M, et al. Antibacterial effects of orthodontic primer harboring chitosan nanoparticles against the multispecies biofilm of cariogenic bacteria in a rat model. Folia Med (Plovdiv) 2020; 62:817.</mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple">15. Sodagar A, Bahador A, Pourhajibagher M, et al. Effect of addition of curcumin nanoparticles on antimicrobial property and shear bond strength of orthodontic composite to bovine enamel. J Dent (Tehran) 2016; 13(5):373–82.</mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple">16. Bahador A, Lesan S, Kashi N. Eﬀect of xylitol on cariogenic and beneficial oral streptococci: a randomized, double-blind crossover trial. Iran J Microbiol 2012; 4(2):75–81.</mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple">17. Süle J, Kõrösi T, Hucker A, et al. Evaluation of culture media for selective enumeration of bifidobacteria and lactic acid bacteria. Braz J Microbiol 2014; 45(3):1023–30.</mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple">18. Ahn SJ, Lee SJ, Kook JK, et al. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater 2009; 25(2):206–13.</mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple">19. Netto CA, Marcucci MC, Paulino N, et al. Effects of typified propolis on <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus"/><tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> streptococci and lactobacilli: a randomized clinical trial. Braz Dent Sci 2013; 16(2):31–6.</mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple">20. Jasso-Ruiz I, Velazquez-Enriquez U, Scougall-Vilchis RJ, et al. Synthesis and characterization of silver nanoparticles on orthodontic brackets: a new alternative in the prevention of white spots. Coatings 2019; 9(480):1–11.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple">21. Bankova V, Christov R, Kujumgiev A, et al. Chemical composition and antibacterial activity of Brazilian propolis. Z Naturforschung C 1995; 50:167–72.</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple">22. Viuda-Martos M, Ruiz-Navajas Y, Fernandez-Lopez J, et al. Functional properties of honey, propolis, and royal jelly. J Food Sci 2008; 73:R117–124.</mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple">23. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005; 26:343–56.</mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation xlink:type="simple">24. Koo H, Rosalen PL, Cury JA, et al. Effects of compounds found in propolis on <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name></italic> growth and on glucosyltransferase activity. Antimicrob Agents Chemother 2002; 46:1302–9.</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation xlink:type="simple">25. Karpinski TM, Szkaradkiewicz AK. Microbiology of dental caries. J Biol Earth Sci 2013; 3(1):21–4.</mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation xlink:type="simple">26. Zhu B, Macleod LC, Kitten T, et al. <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> biofilm formation &amp; interaction with oral pathogens. Future Microbiol 2018; 13: 915–32.</mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation xlink:type="simple">27. Becker MR, Paster BJ, Leys EJ. Molecular analysis of bacterial species associated with childhood caries. J Clin Microbiol 2002; 40(3):1001–9.</mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation xlink:type="simple">28. Kreth J, Merritt J, Shi W, et al. Competition and coexistence between <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">sanguinis</tp:taxon-name-part></tp:taxon-name></italic> in the dental biofilm. J Bacteriol 2005; 187(21):7193–203.</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation xlink:type="simple">29. Akhavan A, Arab S, Bahador A, et al. Evaluation of the effect of propolis nanoparticles on antimicrobial properties and shear bond strength of orthodontic composite bonded on bovine enamel. J Dent Tehran Univ Med Sci 2019; 16(2):98–107.</mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation xlink:type="simple">30. Ito T, Maeda T, Senpuku H. Roles of salivary components in <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> colonization in a new animal model using NOD/SCID.e2f1<sup>−/−</sup> mice. PLoS One 2012; 7(2):e32063.</mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation xlink:type="simple">31. Culp DJ, Robinson B, Parkkila S, et al. Oral colonization by <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name></italic> and caries development is reduced upon deletion of carbonic anhydrase VI expression in saliva. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 2011; 1812(12):1567–76.</mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation xlink:type="simple">32. Brack CM, Reynolds EC. Colonization of rat molar teeth by <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus"/><tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> streptococci with different salivary agglutination characteristics. Arch Oral Biol 1988; 33(10):695–9.</mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation xlink:type="simple">33. Vanni R, Waldner-Tomic NM, Belibasakis GN, et al. Antibacterial efficacy of a propolis toothpaste and mouthrinse against a supragingival multispecies biofilm. Oral Health Prev Dent 2015; 13(6):531–5.</mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation xlink:type="simple">34. Netto CA, Marcucci MC, Paulino N, et al. Effects of typified propolis on <tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus"/><tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name> streptococci and lactobacilli: a randomized clinical trial. Braz Dent Sci 2013; 16(2):31–6.</mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation xlink:type="simple">35. Malhotra N, Rao SP, Acharya S, et al. Comparative in vitro evaluation of efficacy of mouthrinses against <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name></italic>, <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Lactobacillus</tp:taxon-name-part></tp:taxon-name></italic> and <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Candida</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">albicans</tp:taxon-name-part></tp:taxon-name></italic>. Oral Health Prev Dent 2011; 9(3):261–8.</mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation xlink:type="simple">36. Duailibe SA, Goncalves AG, Ahid FJ. Effect of a propolis extract on <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Streptococcus</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">mutans</tp:taxon-name-part></tp:taxon-name></italic> counts in vivo. J Applied Oral Science: Revista FOB 2007; 15(5):420–3.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
